Where next following the French statement on ADHD?
Hervé Caci
In 2010, HyperSuper, a French attention deficit hyperactivity disorder (ADHD) patient support group, and a number of other scientific societies, requested that the French department of health, the Haute Autorité de Santé (HAS), develop a general set of clinical recommendations for the diagnosis and treatment of ADHD in children and adolescents. Until that time, the neurologic, paediatric and child psychiatric societies of France had not issued a joint statement.
ADHD in practice 2015; 7(3): 57–59
To continue reading this article, please sign in or register.

ADHD in practice is supported by an unrestricted educational grant from MEDICE, with no editorial input into the content of this publication.

ADHD Together logo

ADHD in practice was previously supported by Shire from 2009 to 2016.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly, the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title ADHD in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2019 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: editor@adhdinpractice.co.uk

ISSN 2041-2215 (Print) ISSN 2045-7766 (Online)